Significance of androgen‐deprivation therapy for intermediate‐and high‐risk prostate cancer treated with high‐dose radiotherapy: A literature review

R Aizawa, H Ishikawa, M Kato… - … Journal of Urology, 2024 - Wiley Online Library
The real‐world benefits of adding androgen‐deprivation therapy (ADT) and its optimal
duration when combined with current standard high‐dose radiation therapy (RT) remain …

Low-/high-dose-rate brachytherapy boost in patients with intermediate-risk prostate cancer treated with radiotherapy: Long-term results from a single institution team …

SR Villalba, PM Denia, MJ Pérez-Calatayud… - Journal of …, 2021 - termedia.pl
Results Median overall follow-up for the total cohort was 66.5 months (range, 16-185
months). There were no significant differences in bPFS, overall survival, cause specific …

Long-term results with custom-linked iodine-125 seeds and real-time brachytherapy in low-and intermediate-risk prostate cancer

JL Guinot, J Casanova, V Gonzalez-Perez… - Journal of …, 2022 - termedia.pl
Purpose Prostate carcinoma is increasingly prevalent due to improved life expectancy and
early diagnosis. The suspicion of development of a carcinoma due to elevation of prostate …

Biopsy-free prediction of prostate cancer aggressiveness using deep learning and radiology imaging

P Khosravi, M Lysandrou, M Eljalby, M Brendel, Q Li… - medRxiv, 2019 - medrxiv.org
Abstract Magnetic Resonance Imaging (MRI) is routinely used to visualize the prostate gland
and manage prostate cancer. The Prostate Imaging Reporting And Data System (PI-RADS) …

[HTML][HTML] Факторы прогноза выживаемости больных раком предстательной железы после радикальной дистанционной лучевой терапии (углубленное …

МВ Крупина, АЮ Мотков, ТН Трофимова… - 2024 - voprosyonkologii.ru
Аннотация Цель. Оценка факторов прогноза выживаемости при раке предстательной
железы (РПЖ) у больных, получавших дистанционную лучевую терапию (ДЛТ) в 2016 …